| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | increased fear-related response | 1.48e-05 | 19 | 36 | 3 | MP:0003459 | |
| MousePheno | decreased cardiac muscle relaxation | 6.42e-05 | 5 | 36 | 2 | MP:0020419 | |
| Domain | VWFA | 1.15e-03 | 82 | 47 | 3 | PS50234 | |
| Domain | VWA | 1.23e-03 | 84 | 47 | 3 | SM00327 | |
| Domain | PAS | 1.79e-03 | 25 | 47 | 2 | PF00989 | |
| Domain | PAS_fold | 1.79e-03 | 25 | 47 | 2 | IPR013767 | |
| Domain | VWF_A | 1.98e-03 | 99 | 47 | 3 | IPR002035 | |
| Domain | Ank_2 | 2.07e-03 | 215 | 47 | 4 | PF12796 | |
| Domain | - | 2.40e-03 | 106 | 47 | 3 | 1.10.150.50 | |
| Domain | PAS | 2.93e-03 | 32 | 47 | 2 | SM00091 | |
| Domain | SAM/pointed | 3.18e-03 | 117 | 47 | 3 | IPR013761 | |
| Domain | Cadherin | 3.26e-03 | 118 | 47 | 3 | IPR002126 | |
| Domain | PAS | 3.30e-03 | 34 | 47 | 2 | IPR000014 | |
| Domain | PAS | 3.30e-03 | 34 | 47 | 2 | PS50112 | |
| Domain | - | 3.46e-03 | 248 | 47 | 4 | 1.25.40.20 | |
| Domain | ANK | 3.61e-03 | 251 | 47 | 4 | SM00248 | |
| Domain | ANK_REPEAT | 3.71e-03 | 253 | 47 | 4 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 3.77e-03 | 254 | 47 | 4 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.77e-03 | 254 | 47 | 4 | PS50297 | |
| Domain | Cadherin_tail | 3.90e-03 | 37 | 47 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 3.90e-03 | 37 | 47 | 2 | IPR031904 | |
| Domain | Ankyrin_rpt | 4.21e-03 | 262 | 47 | 4 | IPR002110 | |
| Domain | Cadherin_C | 5.01e-03 | 42 | 47 | 2 | IPR032455 | |
| Domain | Cadherin_C_2 | 5.01e-03 | 42 | 47 | 2 | PF16492 | |
| Domain | TPR_2 | 7.03e-03 | 50 | 47 | 2 | PF07719 | |
| Domain | TPR_2 | 7.03e-03 | 50 | 47 | 2 | IPR013105 | |
| Pubmed | Novel testis- and embryo-specific isoforms of the phosphofructokinase-1 muscle type gene. | 1.87e-06 | 2 | 48 | 2 | 15020257 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 38238293 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 33585465 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 26403076 | ||
| Pubmed | Igf1R/InsR function is required for axon extension and corpus callosum formation. | 1.02e-04 | 11 | 48 | 2 | 31318893 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 25552655 | ||
| Pubmed | 1.08e-04 | 1084 | 48 | 8 | 11544199 | ||
| Pubmed | Gli3 controls subplate formation and growth of cortical axons. | 1.22e-04 | 12 | 48 | 2 | 22903314 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 20348416 | ||
| Pubmed | NFE2L3 NEFM CCDC50 TRIM43 PFKM PCDHGA10 PPFIA4 PCDHGA2 GABPA | 1.37e-04 | 1442 | 48 | 9 | 35575683 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 36793543 | ||
| Pubmed | Translational animal models of autism and neurodevelopmental disorders. | 1.68e-04 | 14 | 48 | 2 | 23226954 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 31749685 | ||
| Pubmed | Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development. | 2.21e-04 | 16 | 48 | 2 | 35379703 | |
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 27476503 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 27779093 | ||
| Pubmed | Loss of transforming growth factor-beta 2 leads to impairment of central synapse function. | 2.81e-04 | 18 | 48 | 2 | 18854036 | |
| Pubmed | Neural Stem Cells Direct Axon Guidance via Their Radial Fiber Scaffold. | 2.81e-04 | 18 | 48 | 2 | 32707082 | |
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 20410112 | ||
| Pubmed | 3.49e-04 | 20 | 48 | 2 | 23791195 | ||
| Pubmed | 3.96e-04 | 103 | 48 | 3 | 10574462 | ||
| Pubmed | 4.63e-04 | 23 | 48 | 2 | 37071993 | ||
| Pubmed | 4.63e-04 | 23 | 48 | 2 | 36973253 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 5.29e-04 | 742 | 48 | 6 | 26871637 | |
| Pubmed | 5.48e-04 | 25 | 48 | 2 | 28288114 | ||
| Pubmed | Ccm3, a gene associated with cerebral cavernous malformations, is required for neuronal migration. | 5.48e-04 | 25 | 48 | 2 | 24595293 | |
| Pubmed | Genome-wide association identifies multiple ulcerative colitis susceptibility loci. | 5.93e-04 | 26 | 48 | 2 | 20228799 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.14e-04 | 281 | 48 | 4 | 28706196 | |
| Pubmed | Regulation of archicortical arealization by the transcription factor Zbtb20. | 6.89e-04 | 28 | 48 | 2 | 22689450 | |
| Pubmed | 7.92e-04 | 30 | 48 | 2 | 23042737 | ||
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 7.92e-04 | 30 | 48 | 2 | 16186258 | |
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 24014668 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 27321927 | ||
| Pubmed | Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development. | 8.45e-04 | 31 | 48 | 2 | 25838543 | |
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 29099309 | ||
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 19736351 | ||
| Pubmed | 1.02e-03 | 34 | 48 | 2 | 34963132 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.02e-03 | 34 | 48 | 2 | 30726710 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 1.09e-03 | 853 | 48 | 6 | 28718761 | |
| Interaction | KIF7 interactions | 1.25e-06 | 146 | 48 | 6 | int:KIF7 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.70e-04 | 181 | 40 | 4 | 694 | |
| GeneFamily | Ankyrin repeat domain containing | 1.96e-03 | 242 | 40 | 4 | 403 | |
| ToppCell | Sigmoid-(1)_T_cell-(14)_Tcm|Sigmoid / shred on region, Cell_type, and subtype | 2.36e-06 | 199 | 48 | 5 | ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c | |
| ToppCell | Sigmoid-T_cell-Tcm|Sigmoid / Region, Cell class and subclass | 2.36e-06 | 199 | 48 | 5 | f7c729eaa3c8fd5a05cb6f79cac9b8f199c8092b | |
| ToppCell | Sigmoid-T_cell-Tcm|T_cell / Region, Cell class and subclass | 2.36e-06 | 199 | 48 | 5 | acdf95f4d58df47690f4ae254245bc618f9ac07e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 162 | 48 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 162 | 48 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 162 | 48 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.21e-05 | 168 | 48 | 4 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-05 | 179 | 48 | 4 | 10c7d371937d9d93c12c8d3465430ef9e0c2ec81 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.87e-05 | 187 | 48 | 4 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 187 | 48 | 4 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-05 | 192 | 48 | 4 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.62e-05 | 194 | 48 | 4 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.73e-05 | 195 | 48 | 4 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.73e-05 | 195 | 48 | 4 | c6b5249ac8714b1b701cde31d00ab53f28355c36 | |
| ToppCell | Kidney-Mesangial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 5.85e-05 | 196 | 48 | 4 | 2b2cbe7f96213b7ff50442593f31820d17a2ae94 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.88e-04 | 71 | 46 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | mental development measurement | 6.97e-04 | 25 | 46 | 2 | EFO_0008230 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.73e-03 | 152 | 46 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | ciliopathy (implicated_via_orthology) | 1.79e-03 | 40 | 46 | 2 | DOID:0060340 (implicated_via_orthology) | |
| Disease | major depressive episode | 2.46e-03 | 47 | 46 | 2 | EFO_0007634 | |
| Disease | motion sickness | 2.56e-03 | 48 | 46 | 2 | EFO_0006928 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 2.67e-03 | 49 | 46 | 2 | EFO_0022256 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.89e-03 | 51 | 46 | 2 | EFO_0022242 | |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 3.23e-03 | 54 | 46 | 2 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | Nonorganic psychosis | 5.22e-03 | 69 | 46 | 2 | C0349204 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VTLEIHHHITERDAD | 6 | Q8TF27 | |
| ELEAALHSHQHDIEQ | 21 | Q6ZTN6 | |
| DHTLAHSLQEQEIEH | 26 | Q8IVM0 | |
| EIVEHLLDHGAEVNH | 691 | Q9ULJ7 | |
| EVTAELHHTHKELDD | 501 | Q9P209 | |
| EISEAKHDHHLVEDL | 156 | Q6IC83 | |
| DLQEELRHREHHISE | 871 | Q8NB25 | |
| HHISELDKEVQHLHE | 881 | Q8NB25 | |
| SVRLHELEAHVEHCD | 91 | Q6ZMN7 | |
| LERSLDREEEAVHHL | 196 | Q9Y5H1 | |
| LVHTDATIIHDGHEE | 666 | Q5JSJ4 | |
| EELHQRGHVAHLEDD | 401 | Q8IVH8 | |
| HVEVHARHEERPDEH | 96 | O14558 | |
| PDAHHAESEAHLVEE | 126 | Q06546 | |
| KVHLLSTDHEEEGEH | 216 | Q8NDA2 | |
| EEQHHHKGRLSEEIE | 471 | O75335 | |
| EHSLDREEEAIHHLV | 201 | Q9Y5H3 | |
| EIDLDTSDHAHLEHI | 756 | P08237 | |
| DHCHEAIEITSDDHV | 276 | O95263 | |
| REKHEAVDHSSQHEE | 196 | Q9Y4A8 | |
| DHECESIHPHEVVLR | 781 | Q8N2Q7 | |
| LHHATLHFRSNEEEE | 1201 | Q86WI3 | |
| VADILAHEIHVLEKH | 236 | Q15165 | |
| EDFDIHELHRAHANE | 616 | Q9H992 | |
| HEDLGHDHVSHLDIL | 101 | Q9ULF5 | |
| HIHLKEHQETIDELR | 1241 | Q02224 | |
| QHLHVEDVDTHQDEL | 1091 | P0C091 | |
| HHPIEEAAEEHREKL | 126 | Q96BQ3 | |
| LEDQLHDLTDLHQHE | 336 | Q9ULS5 | |
| RELRETEHLLHDENE | 76 | Q9UGC7 | |
| ERDVIYEEESRHHHS | 551 | Q9UPW6 | |
| QEREHSVHDSVELHL | 376 | Q9P0U3 | |
| ELHEHTFDHILAAVE | 471 | Q14940 | |
| HAEDVEGIRHSHLDL | 371 | Q8IXF0 | |
| EELRHHFRVEHAVAE | 216 | Q16512 | |
| HHHHHRVPREEDEEV | 416 | P23327 | |
| KHEVHFLHEESILER | 311 | P40692 | |
| AEKHLHFVDVDDLHI | 186 | Q6PCB0 | |
| HHENDVKTIHLEDVV | 201 | Q8TAM2 | |
| HEHGHSEVLLEDVEH | 131 | Q96LW9 | |
| HLGEHRDRFEDHEIE | 1681 | Q9BYB0 | |
| EVIHRLRGHDDEIHS | 186 | Q8TEQ6 | |
| LRQLRTDTEDEHSHH | 146 | Q8N0Z6 | |
| HQEETQHHTEEALRE | 361 | Q14CB8 | |
| EHLHAHQEQTEELHL | 646 | O43167 | |
| HILQEHVDLHLEENS | 206 | Q96AP4 | |
| EIILNHRDDHSEELD | 266 | Q9UL62 | |
| REEGSHEQDELHHRD | 271 | Q9NV66 | |
| VQLDSDHLEEDIHRL | 171 | P07197 |